Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Production of the first batches of DHA



Libourne 5 January 2017 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has confirmed that production has begun on schedule for the first batches of microalgae oil that is naturally rich in DHA.


DHA is a highly sought-after essential fatty acid (Omega-3) known for its role in the prevention of numerous illnesses. It is recognized for its beneficial effects on the brain (tissue, healthy development and increase in intellectual capacity) and the heart (reduction in triglycerides, cholesterol and the risk of cardiovascular disease).


Production was launched by Fermentalg partner ARD which specializes in bio-refining, industrial biotechnologies and bio-based chemistry and is located in Pomacle in the Marne region (51).


The first batches are in the process of being refined and will be delivered to several potential partners as part of a pre-launch campaign.


Philippe Lavielle, Chairman and CEO of Fermentalg, said: "I would like to congratulate the teams at Fermentalg and at our partner, ARD, for the remarkable work they have accomplished within the deadlines announced. We can now get to work on the commercial aspects of the market launch for our innovation."


About Fermentalg


Based in Libourne (Gironde), Fermentalg is an industrial biotechnology company and a global leader in the production of oils and proteins derived from the fermentation of microalgae. Its primary markets are the human nutrition and animal feed sectors and the green chemistry industry. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.



 

Press Relations:
 

Investor Relations:


 
 


ACTUS finance & communication

Alexandra Prisa

Tel: +33 (0)1 53 67 36 90

[email protected]
ACTUS finance & communication

Jérôme Fabreguettes-Leib

Tel: +33 (0)1 53 67 36 78

[email protected]




Regulated information

News releases under ongoing reporting obligations:

- other releases

Full and original press release in PDF:


https://www.actusnews.com/documents_communiques/ACTUS-0-46913-2017-01-05-FERMENTALG-PROD-DHA-vDEF-EN.pdf


Receive by email the next press releases of the company by registering on
www.actusnews.com, it's free



Source: Actusnews

Fermentalg S.A. Aktie

0,42 €
0,36 %
Ein geringer Gewinn bei Fermentalg S.A. heute, um 0,36 %.

Like: 0
Teilen

Kommentare